FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3157305846> ?p ?o ?g. }

• W3157305846 abstract "The development of blood-based biomarker tests that are accurate and robust for Alzheimer's disease (AD) pathology have the potential to aid clinical diagnosis and facilitate enrollment in AD drug trials. We developed a high-resolution mass spectrometry (MS)-based test that quantifies plasma Aβ42 and Aβ40 concentrations and identifies the ApoE proteotype. We evaluated robustness, clinical performance, and commercial viability of this MS biomarker assay for distinguishing brain amyloid status.We used the novel MS assay to analyze 414 plasma samples that were collected, processed, and stored using site-specific protocols, from six independent US cohorts. We used receiver operating characteristic curve (ROC) analyses to assess assay performance and accuracy for predicting amyloid status (positive, negative, and standard uptake value ratio; SUVR). After plasma analysis, sites shared brain amyloid status, defined using diverse, site-specific methods and cutoff values; amyloid PET imaging using various tracers or CSF Aβ42/40 ratio.Plasma Aβ42/40 ratio was significantly (p < 0.001) lower in the amyloid positive vs. negative participants in each cohort. The area under the ROC curve (AUC-ROC) was 0.81 (95% CI = 0.77-0.85) and the percent agreement between plasma Aβ42/40 and amyloid positivity was 75% at the optimal (Youden index) cutoff value. The AUC-ROC (0.86; 95% CI = 0.82-0.90) and accuracy (81%) for the plasma Aβ42/40 ratio improved after controlling for cohort heterogeneity. The AUC-ROC (0.90; 95% CI = 0.87-0.93) and accuracy (86%) improved further when Aβ42/40, ApoE4 copy number and participant age were included in the model.This mass spectrometry-based plasma biomarker test: has strong diagnostic performance; can accurately distinguish brain amyloid positive from amyloid negative individuals; may aid in the diagnostic evaluation process for Alzheimer's disease; and may enhance the efficiency of enrolling participants into Alzheimer's disease drug trials." @default.
• W3157305846 created "2021-05-10" @default.
• W3157305846 creator A5006910059 @default.
• W3157305846 creator A5007730505 @default.
• W3157305846 creator A5010479640 @default.
• W3157305846 creator A5022462599 @default.
• W3157305846 creator A5025127149 @default.
• W3157305846 creator A5033783684 @default.
• W3157305846 creator A5041929869 @default.
• W3157305846 creator A5043503442 @default.
• W3157305846 creator A5045117757 @default.
• W3157305846 creator A5047378145 @default.
• W3157305846 creator A5059989970 @default.
• W3157305846 creator A5063130715 @default.
• W3157305846 creator A5069360703 @default.
• W3157305846 creator A5084793720 @default.
• W3157305846 creator A5088998527 @default.
• W3157305846 date "2021-05-01" @default.
• W3157305846 modified "2023-10-16" @default.
• W3157305846 title "A blood-based diagnostic test incorporating plasma Aβ42/40 ratio, ApoE proteotype, and age accurately identifies brain amyloid status: findings from a multi cohort validity analysis" @default.
• W3157305846 cites W1031095229 @default.
• W3157305846 cites W1951070310 @default.
• W3157305846 cites W1965017740 @default.
• W3157305846 cites W2006617902 @default.
• W3157305846 cites W2057511092 @default.
• W3157305846 cites W2106156541 @default.
• W3157305846 cites W2116709840 @default.
• W3157305846 cites W2117047219 @default.
• W3157305846 cites W2127108221 @default.
• W3157305846 cites W2167320419 @default.
• W3157305846 cites W2173280183 @default.
• W3157305846 cites W2176161796 @default.
• W3157305846 cites W2327547544 @default.
• W3157305846 cites W2328176404 @default.
• W3157305846 cites W2562595262 @default.
• W3157305846 cites W2594595110 @default.
• W3157305846 cites W2736518852 @default.
• W3157305846 cites W2754967293 @default.
• W3157305846 cites W2775139260 @default.
• W3157305846 cites W2785757836 @default.
• W3157305846 cites W2897862050 @default.
• W3157305846 cites W2900969253 @default.
• W3157305846 cites W2902379727 @default.
• W3157305846 cites W2903768765 @default.
• W3157305846 cites W2906702113 @default.
• W3157305846 cites W2911487980 @default.
• W3157305846 cites W2919531383 @default.
• W3157305846 cites W2930696305 @default.
• W3157305846 cites W2952761287 @default.
• W3157305846 cites W2955490802 @default.
• W3157305846 cites W2966365568 @default.
• W3157305846 cites W2966904536 @default.
• W3157305846 cites W2981311909 @default.
• W3157305846 cites W2989446795 @default.
• W3157305846 cites W3088634533 @default.
• W3157305846 cites W3093546635 @default.
• W3157305846 cites W4210987525 @default.
• W3157305846 doi "https://doi.org/10.1186/s13024-021-00451-6" @default.
• W3157305846 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8088704" @default.
• W3157305846 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33933117" @default.
• W3157305846 hasPublicationYear "2021" @default.
• W3157305846 type Work @default.
• W3157305846 sameAs 3157305846 @default.
• W3157305846 citedByCount "75" @default.
• W3157305846 countsByYear W31573058462021 @default.
• W3157305846 countsByYear W31573058462022 @default.
• W3157305846 countsByYear W31573058462023 @default.
• W3157305846 crossrefType "journal-article" @default.
• W3157305846 hasAuthorship W3157305846A5006910059 @default.
• W3157305846 hasAuthorship W3157305846A5007730505 @default.
• W3157305846 hasAuthorship W3157305846A5010479640 @default.
• W3157305846 hasAuthorship W3157305846A5022462599 @default.
• W3157305846 hasAuthorship W3157305846A5025127149 @default.
• W3157305846 hasAuthorship W3157305846A5033783684 @default.
• W3157305846 hasAuthorship W3157305846A5041929869 @default.
• W3157305846 hasAuthorship W3157305846A5043503442 @default.
• W3157305846 hasAuthorship W3157305846A5045117757 @default.
• W3157305846 hasAuthorship W3157305846A5047378145 @default.
• W3157305846 hasAuthorship W3157305846A5059989970 @default.
• W3157305846 hasAuthorship W3157305846A5063130715 @default.
• W3157305846 hasAuthorship W3157305846A5069360703 @default.
• W3157305846 hasAuthorship W3157305846A5084793720 @default.
• W3157305846 hasAuthorship W3157305846A5088998527 @default.
• W3157305846 hasBestOaLocation W31573058461 @default.
• W3157305846 hasConcept C121332964 @default.
• W3157305846 hasConcept C126322002 @default.
• W3157305846 hasConcept C142724271 @default.
• W3157305846 hasConcept C143998085 @default.
• W3157305846 hasConcept C185592680 @default.
• W3157305846 hasConcept C2778217198 @default.
• W3157305846 hasConcept C2781197716 @default.
• W3157305846 hasConcept C2989005 @default.
• W3157305846 hasConcept C43346845 @default.
• W3157305846 hasConcept C55493867 @default.
• W3157305846 hasConcept C58471807 @default.
• W3157305846 hasConcept C62520636 @default.
• W3157305846 hasConcept C71924100 @default.
• W3157305846 hasConcept C72563966 @default.
• W3157305846 hasConcept C76318530 @default.
• W3157305846 hasConcept C90924648 @default.

• next